Conference LibraryGated
UB-VV100 · Umoja Biopharma · in vivo CAR-T via VivoVec
Umoja Biopharma 主要 pipeline candidate · VivoVec 第三代 immune-shielded lentiviral 平台生成 in vivo T cell-targeted CAR。 Per JITC 2023 (PMID 36918221 · WebFetch verified 2026-05-16): UB-VV100 = clinical candidate variant of VivoVec · "anti-CD3 single-chain variable fragment on the surfa…
- Type
- product
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_intel_seed_2026-05-16
- evidence_grade
- A
- category
- in_vivo_car_t_lentiviral
- status
- verified
- instance_tag
- sunvax-antibody-2025
- modality
- lentiviral
- target_cell_type
- human T cell (in vivo via VivoVec · anti-CD3 scFv-targeted)
- cargo
- dna
- application
- in vivo CD19 CAR-T therapeutic candidate · lymphodepletion-free framework
- development_stage
- preclinical
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.